Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma
Open Access
- 1 April 2022
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 11 (4) , 669-677
Abstract
Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma Zhewen Wei, Yizhou Zhang, Haizhen Lu, Jianming Ying, Hong Zhao, Jianqiang CaiKeywords
This publication has 20 references indexed in Scilit:
- Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF-κB (P65) Pathway in Hepatocellular Carcinoma CellsJournal of Oncology, 2020
- Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP ConcentrationsFrontiers in Oncology, 2020
- Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progressionCancer Letters, 2020
- Hepatocellular CarcinomaNew England Journal of Medicine, 2019
- Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinomaInternational Journal of Biological Sciences, 2019
- A Low Neutrophil to Lymphocyte Ratio Before Preoperative Chemotherapy Predicts Good Outcomes After the Resection of Colorectal Liver MetastasesJournal of Gastrointestinal Surgery, 2018
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatology International, 2017
- HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathwayInternational Journal of Cancer, 2017
- Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: Can we predict earlier?The Surgeon, 2012
- α-FetoproteinArchives of Disease in Childhood - Education & Practice Edition, 2011